Resistance reversal by RNAi silencing of MDR1 in CML cells associated with increase in imatinib intracellular levels (Q80147873)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429432%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

title

Resistance reversal by RNAi silencing of MDR1 in CML cells associated with increase in imatinib intracellular levels (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429432%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429432%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Laurent Arthur Decosterd

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429432%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1

N Widmer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429432%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

G Untergasser

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429432%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

A Fayet

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429432%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

T Buclin

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429432%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

12 April 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429432%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429432%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429432%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429432%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

1561-2; author reply 1562-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17429432%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.leu.2404671

29 December 2019

exact match

0 references

cites work

OCT-1-mediated influx is a key determinant of the intracellular uptake of imatinib but not nilotinib (AMN107): reduced OCT-1 activity is the cause of low in vitro sensitivity to imatinib

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404671

7 January 2021

hOCT 1 and resistance to imatinib

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404671

7 January 2021

The role of P-glycoprotein in imatinib resistance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404671

7 January 2021

Overexpression of P-glycoprotein in K562 cells does not confer resistance to the growth inhibitory effects of imatinib (STI571) in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404671

7 January 2021

Loss of P-glycoprotein expression in hematopoietic stem cells does not improve responses to imatinib in a murine model of chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404671

7 January 2021

RNAi-mediated knockdown of P-glycoprotein using a transposon-based vector system durably restores imatinib sensitivity in imatinib-resistant CML cell lines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404671

7 January 2021

Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404671

7 January 2021